AGREEMENT TO CONVERT DEBT TO EQUITYAgreement to Convert Debt to Equity • April 3rd, 2023 • 60 Degrees Pharmaceuticals, Inc. • Pharmaceutical preparations
Contract Type FiledApril 3rd, 2023 Company IndustryThis Agreement to Convert Debt to Equity (the “Agreement”) effective as of the 31st day of December, 2021 between 60° Pharmaceuticals, LLC, a limited liability company organized and operating under the laws of Washington, District of Columbia (“Company”), and Geoffrey Dow (“Creditor”), as follows:
AGREEMENT TO CONVERT DEBT TO EQUITYAgreement to Convert Debt to Equity • January 31st, 2023 • 60 Degrees Pharmaceuticals, Inc. • Pharmaceutical preparations
Contract Type FiledJanuary 31st, 2023 Company IndustryThis Agreement to Convert Debt to Equity (the “Agreement”) effective as of the 31st day of December, 2021 between 60° Pharmaceuticals, LLC, a limited liability company organized and operating under the laws of Washington, District of Columbia (“Company”), and Geoffrey Dow (“Creditor”), as follows:
AGREEMENT TO CONVERT DEBT TO EQUITYAgreement to Convert Debt to Equity • December 23rd, 2022 • 60 Degrees Pharmaceuticals, Inc. • Pharmaceutical preparations
Contract Type FiledDecember 23rd, 2022 Company IndustryThis Agreement to Convert Debt to Equity (the “Agreement”) effective as of the 31st day of December, 2021 between 60° Pharmaceuticals, LLC, a limited liability company organized and operating under the laws of Washington, District of Columbia ( “Company”), and Geoffrey Dow (“Creditor”), as follows: